Stock Screener App

Frei -

Installieren

2.76

5.34% 0.14

after-market

Handel nachbörslich: 2.78 0.02 +0.72%

Esperion Therapeutics Inc (ESPR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ESPR? Forum Prognose Aktiensplit

Finanzdaten der Esperion Therapeutics Inc-Aktie (ESPR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	92.93% 168.45	87.31	-	65.00	69.11
Operating Expenses	14.45% 83.21	97.27	-	87.09	73.53
Benefits Costs and Expenses	423.98	-	-	-	-
Costs And Expenses	68.94% 164.33	97.27	-	87.09	73.53
Operating Income/Loss	955.84% 85.23	-9.959	-	-22.10	-4.42
Income/Loss From Continuing Operations Before Tax	392.67% -255.53	87.31	-12.72	-40.45	69.11
Income Tax Expense/Benefit	1.841	-	-	-	-
Income/Loss From Continuing Operations After Tax	297.34% 61.83	-31.33	-12.72	-40.45	-21.32
Net Income/Loss	297.34% 61.83	-31.33	-12.72	-40.45	-21.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	95.16% 9.7114	200.74	-	196.13	2.8154
Diluted Average Shares	95.16% 9.7114	200.74	-	196.13	2.8154
Basic Earnings Per Share	300.00% 0.32	-0.16	-	-0.21	-0.11
Diluted Earnings Per Share	300.00% 0.32	-0.16	-	-0.21	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RDY

$13.87

3.12%

RGC

$24.15

1.13%

ELAN

$25.50

2.41%

NBIX

$131.13

2.56%

VTRS

$13.50

1.05%

UTHR

$541.60

1.84%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters